Through the use of omics technologies, the Laboratory of Omics Sciences and Precision Medicine proposes the study of the microbiota (Metagenomics), its function (Transcriptomics), microbial and non-microbial metabolites (Metabolomics) as well as the host (Genomics and Immunomics) in order to develop predictive algorithms of health and disease as well as therapeutic response in the context of personalized and participatory medicine. Based on the cross-regulatory activity between the microbiota and various immunometabolic processes in the host and the resulting association between changes in microbiota composition and numerous metabolic and inflammatory states, The laboratory aims to channel big data obtained through omics-mediated technologies into a broad spectrum of cardiovascular, neurodegenerative, and metabolic diseases in order to arrive at precision medicine based on biomarkers and bioinformatics algorithms.
